tiprankstipranks
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
US Market

BioCryst (BCRX) Income Statement

Compare
2,206 Followers

BioCryst Income Statement

Last quarter (Q3 2024), BioCryst's total revenue was $117.08M, an increase of 34.98% from the same quarter last year. In Q3, BioCryst's net income was $-14.03M. See BioCryst’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 331.41M$ 270.83M$ 157.17M$ 17.81M$ 48.84M
Gross Profit
$ 326.75M$ 264.23M$ 149.91M$ 16.14M$ 44.73M
Operating Expenses
$ 430.46M$ 412.67M$ 327.63M$ 190.89M$ 144.19M
Depreciation and Amortization
$ 1.66M$ 1.44M$ 777.00K$ 748.00K$ 724.00K
EBITDA
$ -116.33M$ -143.85M$ -121.74M$ -167.56M$ -96.28M
Operating Income
$ -103.71M$ -148.44M$ -177.72M$ -174.76M$ -99.45M
Other Income/Expenses
$ -122.52M$ -95.95M$ -4.09M$ -8.06M$ -9.44M
Pretax Income
$ -226.23M$ -244.38M$ -181.81M$ -182.81M$ -108.90M
Net Income
$ -226.54M$ -247.12M$ -184.06M$ -196.57M$ -120.06M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.18$ -1.33$ -1.03$ -1.18$ -1.04
Diluted EPS
$ -1.18$ -1.33$ -1.03$ -1.18$ -1.04
Weighted Average Shares Outstanding
192.20M 185.91M 179.12M 167.27M 115.60M
Weighted Average Shares Outstanding (Diluted)
192.20M 185.91M 179.12M 167.27M 115.60M
Currency in USD

BioCryst Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis